Fear of progression in patients 6 months after cancer rehabilitation—a validation study of the fear of progression questionnaire FoP-Q-12

Hinz, Andreas; Mehnert, Anja; Ernst, Jochen; Herschbach, Peter; Staudinger, Thomas

doi:10.1007/s00520-014-2516-5

Cited by 69 publications

(89 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Differences regarding objective medical data and other clinical characteristic such as the presence of complications like CF-related diabetes or chronic colonization with germs could be assumed. It is known that FoR in patients with cancer differs regarding the clinical characteristics, such as disease severity or form of therapy [52,53]. The small subsample of fathers also limits representativeness of our results regarding gender.…”

Section: Discussionmentioning

confidence: 97%

“…The measure developed for partners [16], which is based on the short form of the FoP questionnaire [3] also revealed more than one factor, as well as further psychometric testing of the short form for patients [52], but finally a one-factor solution was chosen. Although the generation of the short-form was made via EFA and our item pool was generated using clinical judgment, which might entailed the explicit selection of items from the original measure [4] representing the most likely consequences for the parents' lives as well, comparable psychometric results were found.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Fear of disease progression questionnaire for parents: Psychometric properties based on a sample of caregivers of children and adolescents with cystic fibrosis

Fidika

Herle

Herschbach

et al. 2015

Journal of Psychosomatic Research

Self Cite

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 97%

Section: Discussionmentioning

confidence: 99%

Fear of disease progression questionnaire for parents: Psychometric properties based on a sample of caregivers of children and adolescents with cystic fibrosis

Fidika

Herle

Herschbach

et al. 2015

Journal of Psychosomatic Research

Self Cite

View full text Add to dashboard Cite

“…The German version of the FoP-Q-SF is validated in cancer patients and is a reliable instrument, and a total sum score (higher values indicate higher levels of fear of progression) without a standardized cutoff score for clinically relevant level of fear of progression [32, 33]. The questionnaire is administered to participants at baseline (T1) and follow-up (T2).…”

Section: Methodsmentioning

confidence: 99%

Understanding why cancer patients accept or turn down psycho-oncological support: a prospective observational study including patients’ and clinicians’ perspectives on communication about distress

et al. 2017

View full text Add to dashboard Cite

BackgroundInternational standards prioritize introducing routine emotional distress screening in cancer care to accurately identify patients who most need psycho-oncological treatment, and ensure that patients can access appropriate supportive care. However, only a moderate proportion of distressed patients accepts referrals to or uses psycho-oncological support services. Predictors and barriers to psycho-oncological support service utilization are under-studied. We know little about how patients and oncologists perceive the discussions when oncologists assess psychosocial distress with a screening instrument.We aim to 1) assess the barriers and predictors of uptake of in-house psycho-oncological support along the distress screening pathway in cancer patients treated at a University Oncology Outpatient Clinic and, 2) determine how patients and clinicians perceive communication about psychosocial distress after screening with the Distress Thermometer.MethodsThis is a quantitative prospective observational study with qualitative aspects. We will examine medical and demographic variables, cancer patient self-reports of various psychological measures, and aspects of the patient-clinician communication as variables that potentially predict uptake of psycho-oncological support service. We will also assess the patients’ reasons for accepting or refusing psycho-oncological support services. We assess at three points in time, based on paper-and-pencil questionnaires and two patient interviews during the study period. We will monitor outcomes (psycho-oncology service uptake) four months after study entry.DiscussionThe study will improve our understanding of characteristics of patients who accept or refuse psycho-oncological support, and help us understand how patients’ and oncologists perceive communication about psychosocial distress, and referral to a psycho-oncologist. We believe this is the first study to focus on factors that affect uptake or rejection of psycho-oncological support services along the screening and referral pathway. The study 1) combines standard assessment with qualitative data collection, 2) embraces patient and oncologist perspectives, and, 3) focuses on patient-clinician communication about psychosocial issues raised by a standard screening instrument.Our results may improve routine practices and eliminate barriers to adequate health care, and make it easier to recognize patients with high distress levels who underuse the service.

show abstract

“…Fear of cancer recurrence (FCR) is a problem that almost all cancer survivors experience. Traditionally, FCR has been defined as the fear that cancer could return or progress in the same place or in another part of the body . FCR is one of the most prevalent psychological burdens experienced by cancer patients and survivors, with previous researches reporting prevalence rates of FCR ranging between 33% and 97%.…”

Section: Introductionmentioning

confidence: 99%

“…In recently published studies, a variety of factors were found to be associated with the cancer patients’ FCR level. Demographic characteristics such as female gender, young age, living apart or divorce, a higher level of education, and no children have been reported to be related to higher FCR.…”

Section: Introductionmentioning

confidence: 99%

Factors influencing fear of cancer recurrence in patients with breast cancer: Evidence from a survey in Yancheng, China

Niu

Liang

Niu

2019

J of Obstet and Gynaecol

View full text Add to dashboard Cite

Aim To identify the characteristics of fear of cancer recurrence (FCR) in breast cancer patients after surgery and investigate the relationship of FCR with demographic and medical characteristics, quality of life (QOL) and social support. Methods The short version of the Fear of Progression Questionnaire (FoP‐Q‐SF), the functional assessment of cancer therapy for breast cancer (FACT‐B) and the Social Support Rating Scale were administered to the 342 breast cancer patients who had undergone surgical treatment. The analysis was performed to determine potential predictors associated with FCR. Results Of the 465 patients, 342 (73.5%) agreed to take part in the study. The mean age of participants was 51.46 ± 10.50 years (range, 30–81). Of the 342 participants, 92 (26.9%) cases were at Stage I, 131 (38.3%) cases at Stage II, 34 (9.9%) patients at Stage III and 85 (24.9%) patients at Stage IV. Among the 12 items of the FoP‐Q‐SF, the three greatest fears were: Item 10 ‘Worrying that medications could damage the body’, Item 1 ‘Being afraid of disease progression’ and Item 2 ‘Being nervous prior to doctors’ appointments or periodic examinations’. About 68.4% of patients reported the dysfunctional level of fear of progression. Multiple linear regression analysis showed that religious belief, family income, disease stages, social support, QOL were identified as independent predictors for FCR. Conclusion We found that FCR is prevalent in postoperative breast cancer patients, and is influenced by many factors. It is necessary to implement positive intervention measures to alleviate the FCR and improve the QOL of patients.

show abstract

Fear of progression in patients 6 months after cancer rehabilitation—a validation study of the fear of progression questionnaire FoP-Q-12

Abstract: The FoP-Q-12 proved to be a valid instrument for measuring fear of progression in cancer patients.

Cited by 69 publications

References 28 publications

Fear of disease progression questionnaire for parents: Psychometric properties based on a sample of caregivers of children and adolescents with cystic fibrosis

Fear of disease progression questionnaire for parents: Psychometric properties based on a sample of caregivers of children and adolescents with cystic fibrosis

Understanding why cancer patients accept or turn down psycho-oncological support: a prospective observational study including patients’ and clinicians’ perspectives on communication about distress

Factors influencing fear of cancer recurrence in patients with breast cancer: Evidence from a survey in Yancheng, China

Contact Info

Product

Resources

About